Jose Mejia Oneto, M.D., Ph.D.Founder & CEO at ShasqiSpeaker
Agenda Sessions
Tumor Targeting Therapies with CAPAC (Click Activated Protodrugs Against Cancer): A Novel Platform to Overcome Efficacy Limiting Toxicities Associated with ADCs
, 4:15pmView Session